Login

Financial Snapshot

Revenue
TTM
$19.36B
Gross Margin
TTM
25.93%
Net Income
TTM
$944.7M
Current Assets
2026 Q1
$8.108B
Current Liabilities
2026 Q1
$6.730B
Current Ratio
2026 Q1
120.48%
Total Assets
2026 Q1
$31.47B
Total Liabilities
2026 Q1
$18.23B
Book Value
2026 Q1
13.24B
Cash
2026 Q1
$1.239B
P/E
TTM
10.24
Free Cash Flow
TTM
$1.765B

Stock Price

Loading...
Market Cap: $9.6721 Billion

About Fresenius Medical Care AG

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 109,698 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.

Industry: Services-Misc Health & Allied Services, NEC Peers: Centogene N.V.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support